ACLS Provider: Course

Incorrect. Epinephrine is given every 3-5 minutes to enhance coronary and cerebral perfusion during cardiac arrest.

Incorrect. The maximum dose of atropine for bradycardia is 3 mg, with doses given at 0.5 mg intervals every 3-5 minutes.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest and should be corrected with fluid resuscitation.

Incorrect. PETCO2 monitoring helps assess the effectiveness of both ventilation and chest compressions in real-time during CPR.

Incorrect. Adequate oxygenation and ventilation are critical to preventing hypoxia or hyperoxia after ROSC.

Incorrect. Delivering 10 breaths per minute ensures adequate oxygenation without causing hyperventilation.

Incorrect. Symptomatic second-degree AV block type II can progress to complete heart block, requiring pacing.

Incorrect. Optimal for maintaining adequate circulation without risking poor perfusion due to excessive speed.

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. Pediatric defibrillation starts at 2 J/kg to safely deliver an effective shock without causing harm.

Incorrect. While hypoglycemia can cause critical symptoms, it is not included in the H's and T's of reversible causes of cardiac arrest.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. Asystole is a non-shockable rhythm and is treated with high-quality CPR and epinephrine administration.

Incorrect. Pulse checks are performed every 2 minutes during rhythm assessments to evaluate the effectiveness of resuscitation.

Incorrect. TTM is used to reduce neurological injury post-ROSC by maintaining a core temperature of 32-36°C.

Incorrect. Defibrillation should be performed immediately after identifying VF, not delayed up to 10 minutes.

Incorrect. Rhythm checks are performed every 2 minutes during pauses in CPR to evaluate for shockable rhythms.

Incorrect. Atropine is the first-line treatment for symptomatic bradycardia, increasing the heart rate by blocking vagal stimulation.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and administration of epinephrine.

Incorrect. Ventricular fibrillation presents as a disorganized rhythm that requires immediate defibrillation.

Incorrect. Maximum energy for monophasic defibrillators; for biphasic, follow manufacturer recommendations.

Incorrect. PETCO2 monitoring provides continuous feedback on the quality of chest compressions and the effectiveness of resuscitation.

Incorrect. CPR is the primary intervention for PEA, followed by epinephrine and identification of reversible causes.

Incorrect. ROSC signifies the resumption of spontaneous cardiac activity with effective circulation, improving patient survival.

Incorrect. Atropine is given at a dose of 0.5 mg every 3-5 minutes during bradycardia, up to a maximum dose of 3 mg.

Incorrect. Prompt defibrillation within 30 seconds of witnessed VF arrest improves the chance of restoring a perfusing rhythm.

Incorrect. Avoid delays to minimize interruptions in chest compressions and maintain perfusion.

Incorrect. Dopamine is used when atropine is ineffective, improving heart rate and contractility by stimulating beta receptors.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. PEA is treated with CPR, epinephrine, and identifying reversible causes to restore organized electrical activity.

Incorrect. Ventilations are delivered at a rate of 6-8 breaths per minute to prevent hyperventilation.

Incorrect. Epinephrine 1 mg IV/IO is administered every 3-5 minutes during cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Atropine should not exceed a total dose of 3 mg when treating symptomatic bradycardia in adults.

Incorrect. Adenosine is administered as a 0.1 mg/kg rapid IV push for pediatric SVT, followed by a saline flush.

Incorrect. Amiodarone is administered as a 300 mg IV/IO bolus for refractory VF or pulseless VT.

Incorrect. A 15:2 ratio ensures efficient oxygenation and circulation in pediatric patients during two-rescuer CPR.

Incorrect. Rescuers should switch roles every 2 minutes to maintain high-quality chest compressions and prevent fatigue.

Incorrect. Adenosine 6 mg is given as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. The same compression rate as adults ensures adequate perfusion in pediatric patients during CPR.

Incorrect. Administered via rapid IV push, followed by a saline flush to terminate reentrant arrhythmias.

Incorrect. Pulse checks should be limited to 10 seconds to minimize interruptions in chest compressions.

Incorrect. Atropine doses should not exceed 3 mg during bradycardia management to avoid adverse effects.

Incorrect. Rhythm checks should be performed every 2 minutes, coinciding with rescuer role switches, to evaluate for shockable rhythms.

Incorrect. Hypoxia is the most frequent reversible cause of PEA and should be addressed immediately with oxygenation and ventilation.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation in pediatric patients.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be addressed during resuscitation efforts.

Incorrect. Biphasic defibrillators deliver effective shocks within the range of 120-200 J, restoring organized electrical activity.

Incorrect. Rhythm checks should be performed every 2 minutes during CPR, coinciding with compressor role switches.

Incorrect. The jaw thrust maneuver opens the airway without moving the cervical spine, reducing the risk of spinal injury.

Incorrect. High-quality CPR is the primary intervention for PEA, followed by epinephrine administration and addressing reversible causes.

Incorrect. Hypovolemia is a common reversible cause of PEA and should be addressed with rapid fluid resuscitation.

Incorrect. PEA is not a shockable rhythm; it is treated with CPR and addressing reversible causes such as hypoxia or hypovolemia.

Incorrect. Chest compressions for infants should be about 1/3 the depth of the chest, approximately 1.5 inches (4 cm).

Incorrect. Amiodarone stabilizes the myocardium and is given as a bolus for refractory VF or pulseless VT.

Incorrect. PEA is not a shockable rhythm; it is managed with high-quality CPR and addressing the underlying reversible causes.

Incorrect. A compression fraction >80% ensures that the majority of CPR time is spent delivering chest compressions to improve outcomes.

Incorrect. The most reliable method to confirm and monitor placement by measuring exhaled CO?.

Incorrect. Indicates effective chest compressions and blood circulation during resuscitation.

Incorrect. Lidocaine is an alternative antiarrhythmic for refractory VF, dosed at 1 mg/kg IV/IO.

Incorrect. Epinephrine is given to improve perfusion pressure and increase the chance of ROSC in persistent VF.

Incorrect. Continuous chest compressions are performed while ventilations are delivered every 6 seconds when an advanced airway is in place.

Incorrect. Naloxone reverses opioid-induced respiratory depression, restoring normal respiratory function.

Incorrect. First-line treatment to block vagal stimulation and increase heart rate.

Incorrect. Pulseless VT is treated with defibrillation, while synchronized cardioversion is reserved for tachyarrhythmias with a pulse.